Я тут полазил чуток — видать действительно лучше в российские заведения обратиться. Вот надёргал из одной статьи. Там в графике+скан, так что пардон за качество. Но кое-что упоминается:
Acta Astronautica 53 (2003) 665-680
RESEARCH PROGRESS AND ACCOMPLISHMENTS ON INTERNATIONAL SPACE STATION
A second payload, from the University of California, Irvine, was the Protein Crystal Growth-Enhanced Gaseous Nitrogen Dewar (PCG-EGN), an enhancement of a passive protein crystallization facility that had flown seven times on Mir. The apparatus requires no power and no crew involvement other than transfer to and from ISS, and was therefore suitable for this time period. The PCGEGN, containing 635 samples of 21 different proteins, was transferred to the Zarya module, where the crystallization process took place, and then returned on the next Shuttle flight, for a total space flight duration of 46 days. Some of the results of this experiment have been
published in the scientific literature (Barnes, Acta Crystallogr. D Biol. Crystallogr. 2002).
The two EXPRESS racks that arrived on STS 100/6A contained several payloads in research areas such as microgravity measurements, biotechnology, fluid physics as well as the first commercial payloads on ISS. EXPRESS Rack 1 was transferred and activated during the docked phase, and four powered payloads, CGBA, Commercial Protein Crystal Growth (CPCG) and two Protein Crystal Growth-Single-locker Thermal Enclosure System (PCG-STES) units, were transferred to it from the Shuttle middeck. The rack provided continuous power and data connections to the payloads for their duration on ISS. The CGBA, a commercial payload, contained an experiment provided by Bristol Myers to study bacterial fermentation and antibiotic production in microgravity. Unfortunately, due to an internal software problem, the CGBA failed after a few weeks, prematurely terminating the experiment. The experiment was eventually reflown during Expedition 4 and successfully completed. The CPCG, another commercial payload, contained 1008 protein samples, and was successfully returned during the STS lOV7A.l mission after 125 days in space. The two PCG-STES units contained three protein crystallization experiments, and both were successfully operated and returned on the STS 104/7A mission after 96 days in space.
A new ppyload for ISS, the Cellular Biolechnology Operations Support Syitep (CI3C?SS) contained four investigations to study cell growth in microgravity, involving colon cancer, pheochromocytoma, ovarian cancer, and renal cells. This was the most complex and crew intensive experiment flown to ISS to date, and was successfully completed during the first two weeks of the expedition. The cells were then placed in an onboard refrigerator and finally returned on the STS 108/UF1 mission in December 2001.
Two different experiments studied protein crystallization in microgravity. The Dynamically Controlled Protein Crystal Growth (DCPCG) investigation not only observed the crystallization process, but also attempted to manipulate it by modulating vapor pressure. The experiment was primarily tele-operated by ground controllers. The Advanced Protein
Crystallization Facility (APCF) experiment, sponsored by the Italian Space Agency (ASI), contained eight different investigations from various European universities. Both experiments were completed successfully, and were returned on STS 108KJFl. Three protein crystallization payloads were flown during Expedition 4. Two PCG-STES units were launched on STS 108KJF1, containing three investigations. The units operated nominally, and during a 6-hour powerdown period rnaintaincd the r-cquircti se! ttnlperatuic
They were returned on STS 110/8A. The fourth PCG-EGN flew to ISS on STS 110/8A, carrying 35 1 samples, was stowed in Zarya, and successfully returned on STS 11 l/UF2. The second ISS flight of the commercial CPCG, carrying about 1,000 samples, was successfully completed between STS 1 IOlSA and STS 11 lAJP2, a duration of 72 days.
The second operation of the CBGSS payload occurred in the two weeks following STS 108/I-%1, containing three investigations to study microgravity growth of renal and tonsillar cells and the production of the hormone erythropoietin. The cell culturing portion of the experiment was carried out successfully and the cells placed in cold stowage. During a 6-hour powerdown, some of the samples may have been compromised by a rise in temperature above the required set point. Near the end of the cold stowage phase, the refrigerator experienced anomalies that caused additional warming of the samples. The samples were returned on STS 110/8A for posUlight analysis. The CGBA launched on STS 1 l0/8A was a reflight of the Bristol Myers Squibb experiment on bacterial fermentation and antibiotic production that failed during Expedition 2. On this flight, the hardware operated normally and the experiment was successfully returned on STS 11 lLJF2.
A new commercial payload, Commercial Biomedical Testing Module (CBTM), flew as a sortie on STS 108/UPl. It contained an experiment to investigate the role of a novel protein in osteoporosis. The experiment was completed successfully.